In June 2026 the MHRA approved oral semaglutide, marketed as the Wegovy pill , the first oral GLP-1 receptor agonist licensed in the UK for weight management (distinct from Rybelsus, a lower-dose oral semaglutide licensed for type 2 diabetes)
As global obesity rates continue to climb, so does the demand for effective, long-term pharmacological solutions beyond lifestyle interventions
BeNourish CoQ10 plus L-Carnitine (30 capsules/bottle) Product image 1 / 1 Basic Product Information 0 no(s) RM 109.00 7,500 PV The final price and PV shown include the coupon discount/benefit
While this feels like a victory for weight loss, skipped meals can lead to a gradual, low-level drop in circulating blood glucose
What to do with results: If markers improved, you have evidence the protocol worked